The steroid hormone, estrogen, plays an important role in various physiological events which are mediated via its nuclear estrogen receptors, ER and ER . However, the molecular mechanisms that are regulated by estrogen in the uterus remain largely unknown. To identify genes that are regulated by estrogen, the ovariectomized mouse uterus was exposed to 17 -estradiol (E2) for 6 h and 12 h, and the data were analyzed by cDNA microarray. The present study confirms previous findings and identifies several genes with expressions not previously known to be influenced by estrogen. These genes include small prolinerich protein 2A, receptor-activity-modifying protein 3, inhibitor of DNA binding-1, eukaryotic translation initiation factor 2, cystatin B, decorin, secreted frizzled-related protein 2, integral membrane protein 2B and chemokine ligand 12. The expression patterns of several selected genes identified by the microarray analysis were confirmed by RT-PCR. In addition, laser capture microdissection (LCM) was conducted to determine the expression of selected genes in specific uterine cell types. Analysis of early and late responsive genes using LCM and cDNA microarray not only suggests direct and indirect effects of E2 on uterine physiological events, but also demonstrates differential regulation of E2 in specific uterine cell types. These results provide a basic background on global gene alterations or genetic pathways in the uterus during the estrous cycle and the implantation period.
Introduction
The steroid hormones, estrogen and progesterone, play a pivotal role in the development of the reproductive tract and the regulation of the implantation process. The cellular actions of these steroid hormones are mediated through their ability to bind nuclear receptors, which are basically ligand-activated transcription factors. Estrogen receptors (ERs) are known to exist in at least two types, ER and ER , in mammals (Green et al. 1986 , Kuiper et al. 1996 . The estrogen-ER complex directly binds to estrogen response elements on target genes and modulates gene transcription in a ligand-dependent manner, the so-called genomic actions of estrogen (Kousteni et al. 2001) . However, some of the actions of estrogen are mediated by intracellular second messengers or various signal-transduction cascades through nongenomic actions (Angel et al. 2000 , Ralf & Martin 2003 . Together with the brain, the uterus is a major target of estrogen action, the heterogeneous cell types responding differentially to estrogen. To date, relatively few genes have been identified in the uterus that are regulated by estrogen, with the exact molecular pathways of estrogen and the expression patterns of specific uterine cell types being largely unknown (McMaster et al. 1992 , Das et al. 1994 , Wang et al. 1994 , Diane et al. 2000 , Brannvall et al. 2002 .
The aim of this study was to identify early and late responsive genes regulated by estrogen in the mouse uterus and to determine whether estrogen-responsive genes are differentially expressed according to the specific uterine cell types. For elucidation of estrogen-responsive genes in the uterus, we carried out cDNA microarray analysis. The technique of cDNA microarray has been used to profile the genome-wide analysis of gene expression in various uterine tissues such as implantation-interimplantation sites, progesterone-treated, and delayed-implanting uterus (Reese et al. 2001 , Cheon et al. 2002 . We also employed a combination of laser capture microdissection (LCM) and RT-PCR to quantify estrogen-responsive genes in specific cell types of the ovariectomized mouse uterus. Recently, LCM has been used to isolate specific cell types from tissue sections for the purpose of differential gene expression (Green et al. 2003) . Using these techniques, we profiled both early and late responsive genes regulated by estrogen and demonstrated that several responsive genes were differentially expressed in specific cell types of the estrogen-induced uterus.
Materials and Methods

Animals and estrogen treatment
ICR mice were housed within temperature-and lightcontrolled conditions under the supervision of a licenced veterinarian. Mice were maintained on a 12 h light:12 h darkness photoperiod and food and water were available ad libitum. Female mice (6-7 weeks of age) were ovariectomized (OVX) and rested for 14 days before receiving estrogen treatment. They were injected subcutaneously (0·1 ml/mouse) with sesame oil (control group) alone or with 17 -estradiol (Sigma, St Louis, MO, USA; 300 ng/ mouse; experimental group) dissolved in sesame oil. Mice were killed and uterine horns were collected 6 h or 12 h after injection. Uteri collected from both oil-treated and estrogen-treated mice were used for the microarray and LCM studies. Half the uterus was immediately frozen in liquid nitrogen for RNA isolation as described below and the remaining tissue was embedded in Tissue-Tek (Sakura Finetek, Torrance, CA, USA) for LCM. All animal experiments were performed in accordance with the Ulsan University Guide for the Care and Use of Laboratory Animals.
RNA isolation for cDNA microarray
Uterine tissues collected from nine female mice in each group were pooled, snap frozen, and homogenized by mortar in liquid nitrogen. For cDNA microarray analysis, total RNA was extracted using TRIZOL reagent (InVitrogen, Carlsbad, CA, USA) and purified using RNeasy total RNA isolation kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. DNA was digested using an RNase-free DNase set (Qiagen) during RNA purification. Total RNA was quantified by spectrophotometer and its integrity was assessed by running on a denaturing 0·8% agarose gel. Prior to use in cDNA microarray analysis, each uterine RNA sample obtained via the OVX/estrogen treatment/6-h/12-h protocols was validated by assaying for up-regulated or downregulated genes which are known to be regulated by estrogen in the mouse uterus as markers of estrogen responsiveness.
cDNA microarray and data analysis
To analyze early and late estrogen-responsive genes in the uterus, total uterine RNA was extracted 6 h and 12 h after the injection of estrogen to ovariectomized mice (OVX/ estrogen treatment/6-h and 12-h protocol). Profiling of estrogen-regulated gene expression was analyzed with a TwinChip Mouse-7·4K (Digital Genomics, Seoul, Korea) consisting of 7616 mouse cDNA clones. Each total RNA sample (20 µg) was reverse-transcribed with Cy3-(for oil-treated group) or Cy5 (for estrogen-treated group)-conjugated dUTP (Amersham Pharmacia Biotech, Piscataway, NJ, USA), using SuperScript II (Gibco BRL, Rockville, MD, USA) and oligo(dT) 18 primer (Ambion, Austin, TX, USA) in a reaction volume of 20 µl according to the method suggested by the manufacturer. After the labeling reaction for 1 h at 42 C, unincorporated fluorescent nucleotides were cleaned up using Microcon YM-30 column (Millipore, Bedford, MA, USA). The Cy3-and Cy5-labeled cDNA probes were mixed together and hybridized to a microarray slide. After overnight at 65 C, the slide was washed twice with 2 SSC containing 0·1% SDS for 5 min at 42 C, once with 0·1 SSC containing 0·1% SDS for 10 min at room temperature, and finally with 0·1 SSC for 1 min at room temperature. The slide was dried by centrifugation at 650 r.p.m. for 5 min. Hybridization images on the slide were scanned by Scanarray lite (Packard Bioscience, Boston, MA, USA) and analyzed by GenePix Pro 3·0 software (Axon Instrument, Union City, CA, USA) to obtain gene expression ratios (oil-treated vs estrogen-treated). Logged gene expression ratios were normalized by LOWESS (locally weighted scatter plot smoother) regression (Yang et al. 2002) .
The fluorescent intensity of each spot was calculated by local median background subtraction. We used the robust scatter-plot smoother LOWESS function to perform intensity-dependent normalization for gene expression. Scatter plot analysis was made by Microsoft Excel 2000 (Microsoft, Redmond, WA, USA). Significance analysis of microarray (SAM) was performed for the selection of the genes with significant expression changes (Tusher et al. 2001) . The statistical significance of the differential expression was assessed by computing a q-value for each gene. To determine the q-value we used a permutation procedure, and for each permutation two-sample t-statistics were computed for each gene. Genes were considered differentially expressed when logarithmic gene expression ratios in three independent hybridizations were more than 1 or less than 1, i.e. a twofold difference in expression level, and when the q-value was ,0·1.
Uterine sections and laser capture microdissection
Uterine horns were embedded in Tissue-Tek and frozen in liquid nitrogen. Cryosections (thickness, 6 µm) were cut and mounted onto clean glass slides. After the sections were conterstained with Mayer's hematoxylin, each population of uterine cells (luminal epithelial, stromal and muscle cells) was isolated from these sections using P.A. 
Confirmation of microarray data with semiquantitative RT-PCR analysis
Total RNA from whole uterine tissues was extracted using TRIZOL reagent and purified using an RNeasy total RNA isolation kit (Qiagen) following the manufacturer's instructions. One microgram RNA was reversetranscribed at 42 C for 60 min in 20 µl reaction mixture consisting of oligo(dT)-adapter primer (Takara, Shiga, Japan) and AMV reverse transcriptase XL (Takara). The following PCR was performed in a total volume of 40 µl with 2 µl of the RT reaction mixture, 2 µl 25 mM MgCl 2 , 4 µl 10 PCR buffer (100 mM Tris-HCl, 500 mM KCl, pH 8·3), 4 µl 2·5 mM dNTPs, 10 pmole forward and reverse primer and 1·25 U Taq polymerase (Takara). Total RNA from LCM-captured luminal epithelial, stromal and muscle cells was extracted using RNeasy mini spin column (Qiagen) as described by the manufacturer. The caps were placed in microcentrifuge tubes with RLT buffer which contains denaturing guanidine isothiocyanate. The captured cell areas were collected by centrifugation at 8000 g for 3 min. After vortexing and centrifuging the tubes, the caps were removed and RNA was isolated according to the manufacturer's instructions. To remove any potential genomic DNA contamination, an RNase-free DNase set (Qiagen) was used during RNA purification steps. Finally, 24 µl column-eluted RNA was all reverse-transcribed at 42 C for 60 min in 40 µl reaction mixture consisting of random hexamers (Takara) and AMV reverse transcriptase XL (Takara). The following PCR was performed in a total volume of 40 µl with 4 µl of the RT reaction mixture.
The sequences of the primers used in the RT-PCR investigation and the number of cycles (for whole uterus and LCM) tested to assess the best conditions for achieving linear amplification are listed in Table 3 . RT-PCR from LCM samples was only performed on a few selected up-regulated genes (Fig. 4) . The thermal cycling parameters consisted of denaturing (94 C, 30 s), annealing (60 C, 30 s), and extension (72 C, 30 s). The PCR products were separated by electrophoresis on 1·2% TBE agarose-ethidium bromide gels and visualized under UV light. The images were quantified by densitometric scanning followed by BioID image analysis software (Vilber-Lourmat, Mama La Vallee, Cedex, France), and gene expression was normalized against the density of the corresponding ribosomal protein L-7 (rpL7) PCR product as internal control.
Results
Global analysis of estrogen-regulated genes in the ovariectomized mouse uterus
To confirm reproducibility, experiments were repeated independently three times and relative changes were calculated. The mean values of the intensities of each spot in the three experiments were calculated, and are plotted in Fig. 1 . Of the 7616 genes examined in the OVX/ estrogen treatment/6-h protocol, changes in mRNA expression were detected in 71 genes: 22 were activated and 49 were repressed (Tables 1 and 2 ). Only 0·9% of all genes were activated or repressed more than twofold, with estrogen causing no significant differences in the expression of the remaining 99·1% of the genes. However, in the OVX/estrogen treatment/12-h protocol, 638 genes showed a differential expression ratio of more than twofold or less than 50%: 351 were activated and 287 were repressed. About 8·4% of all genes were activated or repressed (Tables 1 and 2 ). Out of the 638 activated or repressed genes, 433 genes were listed as known genes in GenBank, and 205 genes were unknown. These genes were classified into eight functional categories based on biological functions: cell-cycle-related, immune-related, signal transduction-related, transcription-related, enzymerelated, structure-related, apoptosis-related, and others (including expressed sequence tags and unknown genes).
Confirmation of estrogen-regulated genes
The expression patterns of several genes up-or downregulated by estrogen were confirmed to verify the results of the microarray analysis using semiquantitative RT-PCR. Several genes were selected in different categories of genes: small proline-rich protein 2A (Sprp2A), cystatin B, receptor-activity-modifying protein 3 (Ramp3), proteasome subunit beta type 5 (Psmb5), eukaryotic translation initiation factor 2 (Eif2s2), and inhibitor of DNA binding-1 (Id-1) (up-regulated); and decorin, integral membrane protein 2B (Imp2B), secreted frizzled-related sequence protein 2 (SFR-2), Bach2, chemokine ligand 12 (CXC12), and Id-2 (down-regulated). The primer sets used in the RT-PCR investigation are listed in Table 3 , and the results of semiquantitative RT-PCR analysis are shown in Fig. 2 . Densitometric analysis was performed and intensities were normalized to rpL7 for samples on the same gels. Ratios between oil-and estrogentreated groups were calculated for each PCR product, and mean values of relative intensities were then calculated from three different experiments. These data validate the up-or down-regulation of the above selected genes, and are exactly consistent with the microarray expression profiles.
Analysis of selected gene expression patterns in specific uterine cell types using LCM
To further analyze our findings we investigated gene expression of the selected up-regulated genes in specific uterine cell types using the LCM technique. LCM allows the isolation of specific uterine cell types without contamination from other cell types. Green et al. (2003) showed that mRNA from cells could be successfully isolated by LCM from frozen sections with high efficiency, producing RNA with excellent quality and quantity. We isolated populations of specific uterine cell types from frozen sections stained with Mayer's hematoxylin: luminal epithelial, stromal and muscle cells. Figure 3A shows a representative frozen section (stained with hematoxylin) of an ovariectomized mouse uterus, and subsequent microdissections of specific uterine cells -luminal epithelial cells, muscle cells and stromal cells -are shown in Fig.  3B -D respectively. While Sprp2A, Eif2s2, Id-1, and Psmb5 mRNAs were strongly activated only in luminal epithelial cells, Ramp3 and cystatin B were activated in both luminal epithelial and stromal cells (Fig. 4) . Our qualitative RT-PCR data demonstrate clearly the differential expression of selected genes in specific uterine cell types. 
Discussion
Estrogen plays an important role in various physiological events, but the molecular mechanisms that are regulated by estrogen in the uterus remain largely unknown. Therefore, the identification of novel estrogen-regulated gene pathways is essential to understanding how estrogen regulates various aspects of uterine physiological events, such as the estrous cycle and the implantation process. In the present study, we identified genes that are regulated by estrogen in the ovariectomized mouse uterus exposed to estrogen for 6 h or 12 h using a cDNA microarray. Prior to use in cDNA microarray analysis, each uterine RNA sample obtained via the OVX/estrogen treatment/6-h/ 12-h protocols was validated by assaying for up-regulated (asparagine synthetase and lactoferrin) or down-regulated (glutathione S-transferase and SFR2) genes which are known to be regulated by estrogen in the mouse uterus (Das et al. 1998 , Watanabe et al. 2002 . Watanabe et al. (2002) listed the early estrogen-responsive genes in the ovariectomized mouse uterus. In their microarray data using the OVX/estrogen treatment/6-h protocol, asparagine synthetase is up-regulated (4·4-fold) and glutathione S-transferase is down-regulated (10-fold). Glutathione S-transferase was the most down-regulated gene by estrogen in their study. Das et al. (1998 Das et al. ( , 2000 also showed the differential regulation of lactoferrin and SFR-2 in response to estrogen in the ovariectomized mouse uterus: while uterine levels of lactoferrin mRNA were strongly enhanced at 12 h after estrogen administration, SFR-2 levels were reduced over the same period. We therefore used these genes as markers of estrogen responsiveness (data not shown).
Our microarray results showed that only 0·9% (71 genes) of all genes spotted on the microarray slide were activated or repressed more than twofold in the OVX/ estrogen treatment/6-h protocol, which suggests that direct or fast responses by estrogen are not widespread at the mRNA level in the genes contained in our microarray. Therefore, if a much larger cohort of cDNAs is used in this experiment, we may obtain a different expression outcome. On the other hand, 638 genes showed a differential expression ratio more than twofold or less than 50% in the OVX/estrogen treatment/12-h protocol. About 8·4% of all genes were activated or repressed. It is possible that, in addition to direct or genomic pathways, many indirect or nongenomic pathways affected the patterns of mRNA expression in the latter protocol. Watanabe et al. (2002) reported that generally 5% of all genes were activated or repressed more than threefold by estrogen in an OVX/ estrogen treatment/6-h protocol: 616 genes were determined as estrogen-affected genes, of which 299 were activated and 317 were repressed. It is likely that this difference between their results and ours is due to different strains (they used the C57/BL6/J strain) used in the microarray analysis and the different genes spotted in the microarray techniques.
Even though our results identifying estrogen-regulated genes are quite different from those of Watanabe et al. (2002) , two genes did show the same expression pattern: chemokine orphan receptor 1 and Ramp3; they were slightly increased in the OVX/estrogen treatment/6-h protocol and highly increased in the OVX/estrogen treatment/12-h protocol. Calcitonin, calcitonin-generelated peptide, adrenomedullin, and amylin are related hormones and neuropeptides. Ramp-1, Ramp-2 and Ramp-3, through interaction with the calcitonin receptor, ar e required for the recognition of calcitonin-gene-related peptide, adrenomedullin, and amylin by these receptors (Gangula et al. 2000 , Fischer et al. 2002 . These relationships are enhanced by estrogen, suggesting a role for these genes in uterine estrogen responses.
In the present study, some significant changes in mRNA level were noticed. Activating transcription factors (ATF)-1, ATF-4 and ATF-5 were activated by estrogen in the OVX/estrogen treatment/12-h protocol. It is known that ATF activates gene expression by binding as a homo-or heterodimer to the cAMP response element in the regulatory region of target genes. Although the ATF family is not well characterized in uterine physiological events, such as the estrous cycle and the implantation process, its functions in other tissues suggest an important role in cell proliferation and various signaling mechanisms (Sabbah et al. 1999 , Bleckmann et al. 2002 . In addition, several genes included in the helix-loop-helix family, such as neuroD, musculin, Id-1, and Id-2, were also identified as estrogen-responsive genes in our microarray analyses. Although the associated changes in mRNA levels were not strongly activated or repressed by estrogen, the estrogenresponsiveness of these genes may indicate their involvement in uterine physiological events based on other recent studies. In the mouse, the main sign of blastocyst attachment sites during the implantation period is angiogenesis. Recent work has shown that the expression of Id-1 and Id-3 is required for correct angiogenesis in the neuroectoderm during embryo development; in particular the partial reduction of Id-1 dosage results in an angiogenic defect in adult mice which blocks the vascularization of tumor xenografts (Lyden et al. 1999) . More interestingly, extracellular matrix surrounding endothelial cells was thickened in Id-knockout mice, and thus Id expression may regulate the expression of integrin and matrix metal-loproteinase MMP2 which are required for tumor angiogenesis. Furthermore, the loss of Id function leads to a decrease in vascular endothelial growth factor expression in endothelial cells (Brooks et al. 1994) . These results strongly suggest that endometrial angiogenesis during the estrous cycle or implantation period is directly or indirectly regulated by Id expression under the control of ovarian steroid hormones, prime modulators of cyclic endometrial changes and inducers of local factors produced at the time of implantation.
Interestingly, Sprp2A showed the highest level of upregulation by estradiol in the OVX/estrogen treatment/ 12-h protocol. This gene is reportedly expressed mainly in stratified squamous epithelial cells and controls the differentiation of several cell types (Fischer et al. 1996 , Song et al. 1999 . To date, three families of Sprps have been described and differentially expressed in various types of epithelia (Kartasova et al. 1996 , Fujimoto et al. 1997 . Song et al. (1999) isolated 11 mouse Sprp2 genes and examined the expression patterns of Sprp2 (A-K) genes in mouse epithelial tissues. They found that Sprp2A, Sprp2D and Sprp2F were strongly expressed in the uterus, whereas Sprp2C, Sprp2H, Sprp2I, Sprp2J, and Sprp2K were not detected. In our study, Sprp2A mRNA was strongly activated in luminal epithelial cells compared with stromal and muscle cells using LCM techniques. This regulation suggests that the expression of Sprp2A in luminal epithelial cells has a significant effect on the relationship between epithelial cell function and developing embryos. Although clarification of the function of Sprp2A and the significance of estrogen responsiveness in relation to uterine physiological events have not been identified, recent studies have suggested that the Sprp2A gene family plays a pivotal role in the estrous cycle and the implantation process.
To the best of our knowledge this is the first study to profile early and late responsive genes in mouse using cDNA microarray and LCM techniques. We used the LCM technique to isolate specific uterine cell types from frozen sections stained with Mayer's hematoxylin. Using this technique, we determined the differential expression of several up-regulated genes in specific uterine cell types. In conclusion, our results indicate differential spatiotemporal expression of genes regulated by estrogen, and implicate various genes not previously known to be expressed in ovariectomized mouse uterus. Further investigations in regard to progesterone regulation, spatiotemporal expression, protein expression, and the function of these genes may be necessary to understand the exact mechanisms of estrogen action on the estrous cycle and the implantation process.
for the excellent technical assistance of laser capture microdissection.
Funding
This work was supported by the grant for Asian Institute for Life Sciences (2003-116) .
